Search
Search
腫瘤電場治療(英語︰tumor-treating fields,TTFields),是一種新的癌症治療模式,透過輸出低強度、中等頻率、交變的電場至癌細胞,從而干擾癌細胞的分裂過程,造成 ...
#2. TTFields - Novocure Clinical Trials
腫瘤治療電場(TTFields) 是可以干擾癌細胞分裂的電場。TTFields 是使用一種便攜式醫療器械向癌症區域發送的電場。Novocure® 是試驗將TTFields 療法用於不同類型癌症的 ...
#3. TTFields Therapy
TTFields therapy is an innovative, electric fields-based modality for solid tumor treatment.
#4. 《電》以色列公司NovoCure腫瘤治療電場(TTFields): 非小細胞 ...
腫瘤治療電場(TTFields) 是通過多種機制施加物理力殺死癌細胞的電場。TTFields 不會顯著影響健康細胞,因為它們具有與癌細胞不同的特性(包括分裂率、形態 ...
#5. A Review on Tumor-Treating Fields (TTFields) - PubMed
Tumor-treating fields (TTFields) are a cancer treatment modality that uses alternating electric fields of intermediate frequency (∼100-500 kHz) and low ...
#6. 腫瘤電場治療方案(TTFields)正式引進香港有效延長膠質母細胞 ...
Zai Lab指出TTFields為新興無創癌症治療手法,利用調整特定頻率的電場來破壞細胞分裂,抑制腫瘤生長,導致受影響的癌細胞死亡。根據國際癌症期刊”Clinical ...
#7. Safety and efficacy of tumour-treating fields (TTFields) therapy ...
TTFields are low intensity, intermediate frequency (150–200 kHz), alternating electric fields that cause mitotic arrest and apoptosis ...
#8. The schemes, mechanisms and molecular pathway changes ...
Tumor Treating Fields (TTFields) is a physical therapy that uses moderate frequency (100–300 kHz) and low-intensity (1–3 V/cm) alternating ...
#9. Safety meta-analysis of clinical trials delivering TTFields to the ...
Background: Tumor Treating Fields (TTFields), a non-invasive, loco-regional, antimitotic treatment approved for glioblastoma (GBM), are delivered via ...
#10. Evaluation of Interfraction Setup Uncertainty of GBM Patients ...
Tumor treating fields (TTFields) with concurrent radiotherapy (RT) might improve the outcome of patients with newly diagnosed glioblastoma ...
#11. Tumor Treating Fields (TTFields) Therapy to Manage Brain ...
These TTFields are applied to the patient by electrically insulated surface transducer arrays, which function to disrupt the rapid cell division of cancer cells ...
#12. Tumor Treating Fields (TTFields) Therapy to ... - Clinical Trials
TTFields are applied to the shaved scalp via two pairs of orthogonally positioned transducer arrays. Each pair of transducer arrays will be ...
#13. TT Fields (Tumor Treating Fields) for Brain Tumors
What You Need to Know · TT fields are mild electrical fields that pulse through the skin of the scalp and interrupt cancer cells' ability to divide. · This “field ...
#14. Tumor Treating Fields (TTFields) Reversibly Permeabilize the ...
TTFields are frequency tuned per indication (e.g., 150 kHz for breast, pancreatic, and non-small cell lung cancer [21,22,23]), and they are approved as therapy ...
#15. Study shows TTFields holds promise to potentially trigger ...
“TTFields, in essence, is a vaccinating machine,” Tran said. “It creates a robust inflammatory reaction, causing the tumor cells to burst open, ...
#16. Tumor Treating Fields: At the Crossroads Between Physics ...
TTFields are low intensity (1–3 V/cm), intermediate frequency (100–300 kHz) alternating electric fields delivered to cancer cells. In patients, ...
#17. Randomized, phase 3 LUNAR study. - ASCO Journals
Background: TTFields are electric fields that disrupt processes critical for cancer cell viability. TTFields are delivered by a noninvasive ...
#18. Association of Tumor Treating Fields (TTFields) with survival ...
Background: Tumor Treating Fields (TTFields) became an FDA-approved treatment option for patients with newly diagnosed GBM in 2015 on the ...
#19. TTFields With SOC Induces Clinically Meaningful Survival ...
TTFields are electric fields that exert physical forces on electrically charged intracellular components in dividing cancer cells, which affect ...
#20. Tumor treating fields (TTFields) for patients with glioblastoma
In Switzerland, tumour treating fields (TTFields) for the treatment of newly diagnosed glioblastoma are reimbursed through the statutory ...
#21. TTFields Plus SOC Improves OS in Metastatic NSCLC After ...
“TTFields therapy is a noninvasive anti-cancer treatment modality,” she added, explaining that the electric fields are generated by a portable, ...
#22. TTFields Academy
Tumour Treating Fields (TTFields). An innovative cancer therapy that utilizes alternating electric fields to disrupt cancer cell division and induce cell ...
#23. Animal Studies Evaluating the Safety of Tumor Treating Fields ...
TTFields (200 kHz) are FDA-approved for the treatment of glioblastoma based on phase 3 studies demonstrating efficacy and high safety profile. TTFields are ...
#24. TTFields With SOC Shows Clinically Meaningful Overall ...
TTFields are electric fields that exert physical forces on electrically charged intracellular components in dividing cancer cells, which affect ...
#25. LUNAR: Tumor Treating Field (TTFields) therapy with SOC in ...
Ticiana Leal, MD, Winship Cancer Institute of Emory University, Atlanta, GA, discusses the randomized, Phase III LUNAR study (NCT02973789) ...
#26. Tumor treating fields (TTFields) delay DNA damage repair ...
Tumor Treating Fields (TTFields) are an anti-neoplastic treatment modality delivered via application of alternating electric fields using ...
#27. How Optune Works | Optune® for Glioblastoma
Optune works by creating Tumor Treating Fields (TTFields). TTFields are electric fields that help slow down or stop cancer cell division and may destroy ...
#28. Understanding the mechanisms of action of Tumor Treating ...
Exploring the mechanisms of action of Tumour Treating Fields (TTFields) therapy, this infographic highlights how TTFields selectively...
#29. Modeling Tumor Treating Fields (TTFields) application in ...
Modeling Tumor Treating Fields (TTFields) application in single cells during metaphase and telophase. Abstract: Effects of electric fields on biological ...
#30. Novocure | Therapy for solid tumors called Tumor Treating ...
Novocure (NASDAQ: NVCR) is an oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields.
#31. 860 In vivo effectiveness of tumor treating fields (TTFields ...
Recently, cancer cell death following delivery of TTFields has been shown to stimulate anti-tumor immunity and promote maturation of dendritic cells. The ...
#32. AACR-Novocure Career Development Awards for TTFields ...
Tumor Treating Fields (TTFields) are a novel noninvasive treatment modality utilizing alternating electric fields demonstrating an increase in overall survival.
#33. Alternating electric fields (TTFields) inhibit metastatic spread ...
Tumor treating fields (TTFields) are low intensity, intermediate frequency, alternating electric fields used to treat cancerous tumors.
#34. EP16.01-016 Tumor Treating Fields (TTFields) Application ...
Tumor Treating Fields (TTFields) are electric fields that disrupt cancer cell division via anti-mitotic effects. Recently, cancer cell death following ...
#35. Pivotal, Randomized, Open-label Study of Tumor Treating ...
Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Gemcitabine and Nab-paclitaxel for Front-line Treatment of ...
#36. Delivering Tumor Treating Fields (TTFields) to the ...
TTFields therapy is an approved mono-treatment for recurrent glioblastoma (GBM), and an approved combination therapy with chemotherapy for newly diagnosed GBM ...
#37. 脑胶质瘤的电场治疗 - 腾讯医典
... V/cm)、中频(100~300 kHz)的交变电场”具有抑制肿瘤细胞生长的功能。这种电场被命名为“肿瘤治疗电场(Tumor Treating Fields, TTFields)”。
#38. Tumor Treating Fields dually activate STING and AIM2 ... - JCI
Tumor Treating Fields (TTFields), an approved therapy for glioblastoma (GBM) and malignant mesothelioma, employ noninvasive application of ...
#39. Using Tumor Treating Fields to Combat Mesothelioma
Tumor Treating Fields, also known as TTFields, is a new cancer therapy approved by the U.S. Food and Drug Administration to treat pleural mesothelioma.
#40. A Potential Innovative Treatment Modality in Lung Cancer
TTFields : A Potential Innovative Treatment Modality in Lung Cancer. Search. ESMO · Meeting Calendar · OncologyPRO · Upcoming Meetings · Past Meetings.
#41. Study - European Genome-phenome Archive
Glioblastoma Patient samples were acquired before and after standard chemoradiation or standard chemoradiation+TTFields (Novo-TTF100) treatment.
#42. TTFields Therapy Yields OS Improvement in Second-Line ...
CHICAGO -- Treatment with tumor treating field (TTFields) therapy combined with standard of care improved overall survival versus standard ...
#43. Effect of Tumor Treating Fields (TTFields) (150 kHz ...
Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Pembrolizumab for Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) · Share · Facebook ...
#44. TTFields_肿瘤电场治疗原理 - TeeSim天深科技
TTFields 肿瘤电场疗法—电场分析. 肿瘤电场疗法简介. 肿瘤电场治疗(Tumor Treating Fields,TTFields)是一种利用特定电场干扰细胞分裂的癌症治疗手段。它是将低强度、 ...
#45. Tumor Treating Fields (TTFields) downregulate the Fanconi ...
TTFields increase DNA damage in MPM, as previously seen in glioblastoma and NSCLC. •. TTFields impair DNA damage repair in MPM, specifically the ...
#46. Influence of Treatment With Tumor-Treating Fields on Health ...
Objective To examine the association of TTFields therapy with progression-free survival and HRQoL among patients with glioblastoma. Design, ...
#47. Tumor Treating Fields (TTFields) for Mesothelioma
Tumor treating fields, or TTFields, are an FDA-approved treatment for pleural mesothelioma. They may extend patients' life expectancy.
#48. Evaluating the therapeutic effect of tumor treating fields ...
Background Tumor Treating Fields (TTFields), are a novel, non-invasive tissue ablation technology for treatment of cancer.
#49. TTFields in Unresectable MPM: STELLAR Results in Practice
Tumor-treating fields (TTFields) are a noninvasive, regional treatment based on the delivery of low-intensity alternating electric fields by ...
#50. 腫瘤電場治療-癌症治療邁出新一步 - GBM(膠質母細胞瘤)
近年,一種全新的癌症治療技術「腫瘤電場治療」(tumor treating fields, TTFields)經已面世,為「膠質母細胞瘤」(Glioblastoma Multiforme, GBM)和「惡性胸膜間皮 ...
#51. | The Tumor Treating Fields (TTFields) device and ...
Importance: Tumor Treating Fields (TTFields) are an anti-mitotic treatment approved for treating newly diagnosed and recurrent glioblastoma, and mesothelioma.
#52. "TTFields" - physics finds its way into cancer therapy
The ttfields are targeted at regions of the body where the tumour is. Their frequency is edited and coordinated, so that they can slow cell ...
#53. Survival Benefit of Adjunctive Tumor-Treating Fields ...
TTFields, consisting of low-intensity alternating electric fields, are delivered to the brain via surface transducer arrays adhered to the ...
#54. 电场疗法“引爆”癌细胞,罕见肿瘤患者仅剩1年寿命到长久存活
该公司的Tumor Treatment Fields治疗方法,即电场疗法(TTFields),是2015年来FDA批准的第一种治疗间皮瘤的新疗法。
#55. Tumor-Treating Fields for Glioblastoma and Other Brain Tumors
TTFields are low-intensity, alternating electric charges that prevent proliferation of cancer cells by disrupting mitosis. Patients wear a ...
#56. Introduction to Ttfields Therapy - Academic Accelerator
Moreover, TTFields therapy is currently investigated in a phase III clinical trial for the treatment of advanced Non-Small Cell Lung Cancer (NSCLC).
#57. AACR 2022 Proceedings: Part B April 11-13 - Google 圖書結果
Introduction: Tumor Treating Fields (TTFields) are alternating electric fields, delivered noninvasively to the tumor site. TTFields therapy is currently ...
#58. Principles and Technologies for Electromagnetic Energy Based ...
This experiment indicates that the effect of TTFields is frequency dependent with an optimal response observed at different frequencies for different cell ...
#59. Alternating Electric Fields Therapy in Oncology: A Practical ...
Table 10.2 Clinical trials of TTFields in extracranial solid tumor (non-central nervous system) malignancies. Trial Phase Treatment Endpoint Status NCT ...
#60. Bragar Eagel & Squire, P.C. Is Investigating Zai Lab, Bowlero ...
It said that its tumor treating fields (TTFields) therapy, which uses skin patches to deliver electric fields to areas of the body, ...
#61. Advances in brain tumors diagnosis and treatment
If a patient developed skin toxicity prohibiting continued use of TTFields during the concurrent phase of treatment, TTFields would be discontinued while ...
#62. Bragar Eagel & Squire, P.C. Is Investigating Zai Lab,
It said that its tumor treating fields (TTFields) therapy, which uses skin patches to deliver electric fields to areas of the body, ...
#63. Brain and Human Body Modeling: Computational Human Modeling ...
Such an understanding will facilitate moving TTFields' clinical efficacy toward the 100% ideal achieved in vitro. Acknowledgements Thanks to Cornelia Wenger ...
#64. NovoCure Limited Investors with Substantial Losses ... - Fox 59
On January 5, 2023, NovoCure announced positive topline results for its LUNAR study, which sought to evaluate the use of TTFields in the ...
#65. AACR 2019 Proceedings: Abstracts 2749-5314 - Google 圖書結果
cohort, leading us to hypothesize that TTFields activate the intrinsic Bcl2mediated apoptotic signaling pathway. Future modeling will seek to tie disruption ...
#66. Bragar Eagel & Squire, P.C. Is Investigating Zai Lab, Bowlero, a
It said that its tumor treating fields (TTFields) therapy, which uses skin patches to deliver electric fields to areas of the body, when used with standard ...
#67. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ...
Despite reporting that patients receiving TTFields combined with standard therapies achieved median overall survival (“OS”) of 13.2 months, ...
#68. NovoCure Limited Investors with Substantial Losses Have ...
On January 5, 2023, NovoCure announced positive topline results for its LUNAR study, which sought to evaluate the use of TTFields in the ...
#69. SVB Securities Initiates NovoCure at Outperform With $51 ...
TTFields are electric fields that exert physical forces to kill cancer cells via a variety of mechanisms. TTFields therapy has applicability ...
#70. NovoCure Limited Investors with Substantial Losses ... - Fox 4
On January 5, 2023, NovoCure announced positive topline results for its LUNAR study, which sought to evaluate the use of TTFields in the ...
#71. NovoCure Limited Investors with Substantial Losses Have ...
On January 5, 2023, NovoCure announced positive topline results for its LUNAR study, which sought to evaluate the use of TTFields in the treatment of non-small ...
#72. Shareholder Alert: Pomerantz Law Firm Investigates Claims ...
Despite reporting that patients receiving TTFields combined with standard therapies achieved median overall survival ("OS") of 13.2 months, ...
#73. 中国头部药企创新力来源- 市场专区 - 生物谷
... 药物担当创新主力军,获批数量达59款(67%),生物制剂获批28款,其体量(32%)约为小分子的1/2,另有1款肿瘤电场治疗TTFields拿到上市通行证。
#74. Handbook of Neuro-Oncology Neuroimaging
... and Radiation Necrosis 236 Future Directions 239 Conclusion 239 References 239 25. TTFields Therapy: Preclinical and Clinical Data JOSHUA LANTOS ...
#75. New Insights into Glioblastoma: Diagnosis, Therapeutics and ...
Patients treated with TTFields (plus TMZ) showed a median survival rate of 24.9 months and a 5-year survival of 29.3% [51].
#76. Pomerantz Law Firm Investigates Claims On Behalf of ... - KNWA
Despite reporting that patients receiving TTFields combined with standard therapies achieved median overall survival ("OS") of 13.2 months, ...
#77. Pomerantz Law Firm Investigates Claims On Behalf of ...
Despite reporting that patients receiving TTFields combined with standard therapies achieved median overall survival ("OS") of 13.2 months, ...
#78. 2023-08-04 | NDAQ:NVCR | Press Release | Novocure Ltd
Despite reporting that patients receiving TTFields combined with standard therapies achieved median overall survival ("OS") of 13.2 months, ...
#79. Clinical Trial 21937 - Moffitt Cancer Center
... Tolinapant, Trastuzumab, Triciribine Phosphate monohydrate, Triptorelin, TSR-042, TST001, TTFields, UCART123v1, UCART123v1.2, Ustekinumab/placebo ...
#80. NovoCure Limited Investors with Substantial Losses ... - WCBD
On January 5, 2023, NovoCure announced positive topline results for its LUNAR study, which sought to evaluate the use of TTFields in the ...
#81. NovoCure Limited Investors with Substantial Losses ... - WVNS
On January 5, 2023, NovoCure announced positive topline results for its LUNAR study, which sought to evaluate the use of TTFields in the treatment of non-small ...
#82. NovoCure Limited Investors with Substantial Losses ... - WFXR
On January 5, 2023, NovoCure announced positive topline results for its LUNAR study, which sought to evaluate the use of TTFields in the ...
#83. Lawsuit Alert: Investors who lost Money with shares of NovoCure
... and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, ...
#84. SHAREHOLDER ALERT: Pomerantz Law Firm ... - PR Newswire
Despite reporting that patients receiving TTFields combined with standard therapies achieved median overall survival ("OS") of 13.2 months, ...
#85. 5 Best Healthcare Stocks to Buy in 2023 | The Motley Fool
TTFields has already been approved for treating glioblastoma (a type of brain cancer) and mesothelioma (a cancer caused by exposure to asbestos). Novocure is ...
#86. Therapy case summary template
... we summarise the landscape of TTFields clinical trials across various cancers and consider how emerging preclinical data might inform future Cohen, ...
#87. BOWL - Bragar Eagel & Squire P.C. Is Investigating Zai Lab...
It said that its tumor treating fields (TTFields) therapy, which uses skin patches to deliver electric fields to areas of the body, ...
#88. SVB Leerink Initiates Coverage on NovoCure with Outperform ...
With its innovative TTFields devices leading the charge against solid tumor cancers worldwide, Novocure is positioned to capitalize on its ...
#89. Bragar Eagel & Squire, P.C. Reminds Investors That Class ...
Despite reporting that patients receiving TTFields combined with standard therapies achieved median overall survival ("OS") of 13.2 months, ...
#90. New York State Common Retirement Fund Has $7.58 Million ...
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) ...
ttfields 在 LUNAR: Tumor Treating Field (TTFields) therapy with SOC in ... 的推薦與評價
Ticiana Leal, MD, Winship Cancer Institute of Emory University, Atlanta, GA, discusses the randomized, Phase III LUNAR study (NCT02973789) ... ... <看更多>